Skip to main content

Advertisement

Log in

A new synthesis of Entacapone and report on related studies

  • Published:
Journal of Chemical Sciences Aims and scope Submit manuscript

Abstract

A new synthesis of the catechol-O-methyltransferase (COMT) inhibitor, entacapone (E-isomer) has been achieved under mild conditions by amine-mediated demethylation of the precursor 2-Cyano-3-(3- hydroxy-4-methoxy-5-nitrophenyl) prop-2-eneamide, wherein the methoxyl group adjacent to a nitro group gets demethylated under nucleophilic attack. Similar demethylation was achieved on ethyl 2-cyano-3-(3, 4-dimethoxy-5-nitrophenyl) prop-2-enoate, 2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylprop-2-enamide, ethyl 2-cyano-3-(3-hydroxy-4-methoxy-5-nitrophenyl) prop-2-enoate and ethyl 2-cyano-3-(4-methoxy-3-nitrophenyl) prop-2-enoate. The scope of demethylation has been studied. Analogues of ethyl 2-cyano-3-(3, 4-dimethoxy-5-nitrophenyl) prop-2-enoate wherein a methoxyl group is not adjacent to a NO 2 group are unaffected and phenolic derivatives yield the amine salts. Entacapone has been converted to salts with organic bases. The crystal structure of the isomer of entacapone (Z-isomer), a significant human metabolite of E-isomer has been established. NMR methods for deriving E and Z geometry and other similar molecules have been successfully established, mainly by studying the proton coupled 13C spectra. Preliminary studies reveal in vitro activity for some compounds against tuberculosis (TB) and dengue.

A new synthesis of entacapone 1 of a designed precursor under very mild conditions is reported. Crystal structure of its Z isomer, NMR methods for establishment of E and Z geometry of benzylidene derivatives are also reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Scheme 2
Scheme 3
Scheme 4
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  1. Axelrod J and Albers W 1959 Carmine and Clemente D J. Neurochem. 5 68

  2. Richard C, Dodel M D, Karla M, Eggert M D, Marika S, Singer M D, Eichhorn E., M D O. P. M D, Wolfgang H and Oertel M D 1998 Mov. Disord. 13 249

  3. Andrew D, Siderowf M D, Robert G, Holloway M D, MPH and Stern M B 2000 Mov. Disord. 15 439

  4. Axelrod J and Tomchick R 1958 J. Biol. Chem. 233 702

  5. Cedarbaum J M 1987 Clin. Pharmacokinet. 13 141

  6. Quinn N P 1984 Drugs 28 236

  7. Bartholini G and Pletscher A 1975 Pharmacol. Ther. [B] 1 407

  8. Mannisto P T and Kakkola S 1999 Phrmacol. Rev. 51 593

  9. Wikberg T, Vuorela A, Ottoila P and Taskinen J 1993 Drug Metab. Dispos 21 81

  10. Pipuri, Honkanen and Haarala 1991 EP Patent 0,426,468

  11. Veera Reddy A and Rajendiran C 2005 WO Patent 2005063693A1

  12. Cziaky Z 2006 WO Patent 2006064296A 1

  13. Bartra Sanmarti M, Solsona Rocabert J G, Palomo Nicolau F E and Molina Ponce A 2008 WO Patent 2008119793

  14. Srikanth G, Ray Uttam Kumar, Srinivas Rao D V N, Badarinath Gupta P, Lavanya P and Islam Aminul 2012 Synth. Commun. 42 1359

  15. Veerareddy A and Reddy G S 2014 Synth. Commun. 44 1274

  16. Kulkarni P P, Kadam A J, Mane R B, Uday V D and Wadgaonkar P P 1999 J. Chem. Res. (S) 394

  17. Buckle D R and Rockell C 1985 J. Chem. Soc., Perkin Trans. 1 2443

  18. Arcadi A, Cacchi S, Del Rosario M, Fabrizi G and Marinelli F 1996 J. Org. Chem. 61 9280

  19. Nishioka H, Nagasawa M and Yoshida K 2000 Synthesis 2 243

  20. Cahn R S 1931 J. Chem. Soc. 1121

  21. Conreaux D, Belot S, Desbordes P, Monteiro N and Balme G 2008 J. Org. Chem. 73 8619

  22. Brescia A, Arents J, Meislich H and Turk A 1973 In Fundamental of chemistry (3rd ed.) (London: Academic press) p.413

  23. Harisha A S, Nayak S P, Nagarajan K, Guru Row T N and Amar A. Hosamani 2015 Tetrahedron Lett. 56 1427

  24. Zhang S J, Zheng X M and Hu W X 2009 Acta Crystallogr. Sect. E 65 2351

  25. Kametani T, Nyu K and Yamanaka T 1971 Chem. Pharm. Bull. 19 1321

  26. Dai G, Shi D, Zhou L and Huaxue L Y 1995 Chinese J. Appl. Chem. 3 103

  27. Sreenivas Reddy L, Sarah J, Bethune Jeff W. Kampf and Nair Rodriguez-Hornedo 2009 Cryst. Growth Des. 9 378

  28. Mitra A K, Banerjee S K and Sharmistha C 2003 J. Indian Chem. Soc. 80 921

  29. Leppanen J, Wegelius E, Nevalainen T, Jarvinen T, Gynther J and Huuskonen J 2001 J. Mol. Struct. 562 129

  30. Ulrich V, Wolfgang V P, Nagarajan K and Nair M D 1978 HeIv. Chim. Acta 61 607

  31. Francisco D, Joaquin T, Gerard Z, Miguel L, Rene M and Jose G 1995 Synth. Commun. 25 753

  32. (a) Saito T, Goto H, Honda K and Fujii T 1992 Tetrahedron Lett. 33 7553; (b) Angeletti E, Canepa C, Martinetti G and Venturello P 1988 Tetrahedron Lett. 29 2261; (c) Prajapti D, Lekhok K C, Snadhu J S and Ghosh A C 1996 J. Chem. Soc., Perkin Trans. 1 959; (d) Chalais S, Laszlo P and Mathy A 1985 Tetrahedron Lett. 26 4453

  33. Hema R, Parthasarathi V, Ravikumar K, Sridhar B and Pandiarajan K 2006 Acta Crystallogr. Sect. E 62 708

  34. Yoo W J and Li C J 2006 J. Org. Chem. 71 6266

  35. Li Z, Li H, Guo X, Cao L, yu Rango, Li H and Pan S 2008 Org. Lett. 10 803

  36. Smith C D, Rosocha G, Mui L and Batey R A 2010 J. Org. Chem. 75 4716

  37. Barluenga J, Riesgo L, Vicente R, Lopez Luis A and Tomas M 2007 J. Am. Chem. Soc. 129 7772

  38. Kingsbury C A, Draney D, Sopchik A, Rissler W and Durham D 1976 J. Org. Chem. 41 3863

  39. Kinnings S L, Liu N, Buchmeier N, Tonge P J, Xie L and Bourne P E 2009 Comput. Biol. 5 7

  40. (a) Steuer C, Gege C, Fischl W, Karl H, Heinonen, Bartenschlager R and Klein C D 2011 Bioorg. Med. Chem. 19 4067; (b) Nitsche C, Steuer C and Klein C D 2011 Bioorg. Med. Chem. 19 7318; (c) Mueller N H, Pattabiraman N, Ansarah-Sobrinho C, Viswanathan P, Pierson T C and Padmanabhan R 2008 Antimicrob. Agents Chemother. 52 3385 41.

  41. Padmanabhan R, Nagarajan K, Rao K S, Shridhara K, Shashiprabha and Harisha A S 2014 WO Patent 2014164667A 1

Download references

Acknowledgements

We thank Alkem laboratories of India for providing research facilities and OSDD CSIR for in vitro anti TB results.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to GURU ROW T N or KUPPUSWAMY NAGARAJAN.

Additional information

Supplementary Information

1H, 13C NMR, HSQC and 2D 1H-1H NOESY spectra for all new compounds are available. available at www.ias.ac.in/chemsci. Crystallographic data 2 (CCDC1027892), 23 (CCDC1027891), 25 (CCDC10 27893), 30 (CCDC1027894) and 32 (1027895) have been deposited at the Cambridge Crystallographic Database Centre and are available on request (http:www.ccdc.cam.ac.uk).

Electronic supplementary material

Below is the link to the electronic supplementary material.

(DOC 14.0 MB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HARISHA, A.S., NAYAK, S.P., S, P.M. et al. A new synthesis of Entacapone and report on related studies. J Chem Sci 127, 1977–1991 (2015). https://doi.org/10.1007/s12039-015-0961-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12039-015-0961-4

Keywords

Navigation